Nicodicosapent

• CAT Number: I008288
• CAS Number: 1269181-69-2
• Molecular Formula: C28H39N3O2
• Molecular Weight: 449.64
• Purity: ≥95%
• Solubility: Soluble in DMSO, not in water
• Storage: Store at -20°C
• IUPAC Name: N-[2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]ethyl]pyridine-3-carboxamide
• InChI: InChI=1S/C28H39N3O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21-27(32)30-23-24-31-28(33)26-20-19-22-29-25-26/h3-4,6-7,9-10,12-13,15-16,19-20,22,25H,2,5,8,11,14,17-18,21,23-24H2,1H3,(H,30,32)(H,31,33)/b4-3-,7-6-,10-9-,13-12-,16-15-
• InChIKey: YYQALOWPCKMFDQ-JLNKQSITSA-N
• SMILES: CCC=CCC=CCC=CCC=CCC=CCCCC(=O)NCCNC(=O)C1=CN=CC=C1

Nicodicosapent (Cat No.:I008288) is a synthetic derivative of eicosapentaenoic acid (EPA), which is a type of omega-3 fatty acid found in fish oil. Nicodicosapent is being developed as a potential treatment for hypertriglyceridemia, a condition characterized by high levels of triglycerides in the blood that can increase the risk of cardiovascular disease. Nicodicosapent is believed to work by reducing the production of very low-density lipoprotein (VLDL) particles in the liver, which are a major source of circulating triglycerides.